Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $4.75 Million - $5.54 Million
-26,621 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $408,649 - $459,001
-2,461 Reduced 8.46%
26,621 $4.91 Million
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $229,723 - $256,670
-1,361 Reduced 4.47%
29,082 $5.06 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $5.09 Million - $5.81 Million
30,443
30,443 $5.68 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.